Vladimir Putin “We discussed this important issue yesterday over a beer...”
Barack OBAMA “You know, my faith is one that admits some doubt...”
Delcath Systems, Inc. (Nasdaq: DCTH) a development stage, specialty pharmaceutical and medical device company focused on oncology, highlighted the Phase III trial data presented on June 5 at the American Society of Clinical Oncology’s 2010 Annual Meeting, comparing percutaneous hepatic perfusion (PHP) with melphalan to the best alternative care for patients with hepatic metastases from [...]
Octapharma USA today announced the first grant recipient of the Octapharma 25th Anniversary Grants Program is the Rush Hemophilia & Thrombophilia Center at Rush University Medical Center. The Octapharma grants program supports clinical or pre-clinical research focused on human protein therapies in hematology, immune therapy, intensive care and emergency medicine. Leonard A. Valentino, M.D., Director [...]
Tibotec Pharmaceuticals today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for TMC278 (rilpivirine), an investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), being studied for once-daily use with other antiretroviral agents in treatment-naive HIV-1-infected adults. If approved, TMC278 will be the third anti-HIV compound to be introduced [...]
Established in 2006, Amgen Scholars is a $27.5 million international initiative of the Amgen Foundation. The opportunity to work with top academic scientists is a cornerstone of the program, with participating universities seeking to match students with faculty members who will both inspire and challenge them. This summer, more than 325 of the brightest undergraduate [...]
Diplomat Specialty Pharmacy, the nation’s largest privately owned specialty pharmacy, announced today that Robert Fleckenstein has joined the Company’s executive team. Mr. Fleckenstein will serve as the Company’s Vice President of Operations overseeing the day-to-day operations of Diplomat’s National Distribution Center, Patient Service Operations, Call Center, Oncology Department and other patient facing services at Diplomat’s [...]
PRA International, a leading Clinical Research Organization, is exhibiting our significant hematology expertise and experience at the European Hematology Association’s (EHA) 15th congress in Barcelona 10-13 June 2010. At PRA’s booth (#202), conference attendees can meet with our lead hematology expert, Ute Berger, M.D., to discuss the key issues and latest developments in hematology drug [...]
Neurim Pharmaceuticals confirmed today that the European Commission (EC) has approved a change in treatment duration with Circadin from 3 to 13 weeks (3 months). Circadin is indicated for the treatment of primary insomnia in patients who are aged 55 or over. The approval was based primarily on data obtained in the latest SOUNDER-SLEEP Phase [...]
Beardsworth Consulting Group, Inc. announces the appointments of Alison Martin, M.D. as the company’s Scientific Advisor, Oncology and Robert W. Malone, M.D. as the company’s Medical Director, Vaccines. Dr. Alison Martin is one of oncology’s respected research leaders with over 20 years of clinical research experience. She joins Beardsworth from the National Cancer Institute (NCI) [...]
ActiveCare, Inc. (OTC Bulletin Board: ACAR) and Vista Therapeutics, Inc. announced today a strategic relationship to develop Nano Biosensors for ActiveCare’s products and services to be utilized by the elderly. These Biosensors will allow ActiveCare to continuously monitor specific chronic diseases commonly occurring in the elderly and thus preventively predict and avoid acute medical events. [...]
Bioheart, Inc., (OTC Bulletin Board: BHRT) announced plans for establishing two Centers of Excellence in the Middle East to provide its cell therapy procedures to patients suffering from congestive heart failure (CHF) and peripheral arterial disease (PAD). Dr. Karl E. Groth, Chairman and CEO, and Peggy A. Farley, Chief Operating and Financial Officer, are now [...]